Sutro Biopharma (STRO) EBITDA Margin Growth (1y) (2018 - 2026)
Powered by 
Analysis
Sutro Biopharma (STRO) EBITDA Margin Growth (1y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 7,666.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1,238.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2,002.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -1,651.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 29,091.00 |
| 10 | Sutro Biopharma | 334.33 Mn | 169.99 Mn | - | -29,852.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -29,852.00 |
| Dec 31, 2025 | -13,584.00 |
| Sep 30, 2025 | 29,723.00 |
| Jun 30, 2025 | 18,414.00 |
| Mar 31, 2025 | 4,127.00 |
| Dec 31, 2024 | -47,861.00 |
| Sep 30, 2024 | -53,710.00 |
| Jun 30, 2024 | 25,413.00 |
| Mar 31, 2024 | -10,179.00 |
| Dec 31, 2023 | 60,817.00 |
| Sep 30, 2023 | -17,572.00 |
| Jun 30, 2023 | -37,454.00 |
| Mar 31, 2023 | 33,033.00 |
| Dec 31, 2022 | -24,137.00 |
| Sep 30, 2022 | 32,277.00 |
| Jun 30, 2022 | -3,402.00 |
| Mar 31, 2022 | -53,393.00 |
| Dec 31, 2021 | -2,874.00 |
| Sep 30, 2021 | -34,755.00 |
| Jun 30, 2021 | 13,842.00 |